European Pharmacopoeia Adopts New Standards To Accelerate mRNA Vaccine Development

New general texts to be published in the European Pharmacopoeia in July 2025 are intended to support the rapidly developing mRNA vaccine field, which has become an increasingly important technology in recent years.